Osteoporosis

A new compound, AP503, has been shown to strengthen bones and muscles in mice by activating the GPR133 receptor, offering potential for osteoporosis treatment.

Scientists found that an experimental compound, AP503, strengthened bones in mice by activating the GPR133 receptor, offering a new approach to fight osteoporosis.

A ten-year study found that tea drinking is linked to slightly higher hip bone density in older women, while consuming over five cups of coffee daily may lead to lower bone density.

A study using zebrafish found that an existing osteoporosis drug could prevent spinal damage, offering a new path for treating back pain.

A study in zebrafish found that an existing osteoporosis drug blocked spinal damage, offering new hope for treating intervertebral disc degeneration and back pain.